Assessing the impact of metabolomic markers on gastric cancer risk: a two-sample Mendelian randomization study
This study identified a set of genetically predicted metabolites associated with GC risk, highlighting the potential utility of metabolite panels and lipid-based biomarkers for risk stratification and early detection. However, further standardization and extensive validation are necessary prior to clinical application.
Authors
- Van Mai Truong (ORCID: https://orcid.org/0000-0002-1473-9485)
- Tho Thi Anh Tran
- Tung Hoang
Institutions
- Vietnam National University Ho Chi Minh City (VN)
- Hanoi Medical University (VN)
- Khanh Hoa General Hospital (VN)
Publication Details
- Journal
- Korean Journal of Family Medicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.4082/kjfm.25.0229
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tập đoàn Vingroup - Công ty CP
- Viet Nam National University Ho Chi Minh City
- Quỹ Đổi mới sáng tạo Vingroup